CUMBERLAND PHARMACEUTICALS INC - 8-K Filing
Cumberland Pharmaceuticals reports Phase 2a ASSIST-SSc trial top-line results for oral ifetroban, demonstrating safety and tolerability in systemic sclerosis patients.
Tickers: $CPIX
Cumberland Pharmaceuticals reports Phase 2a ASSIST-SSc trial top-line results for oral ifetroban, demonstrating safety and tolerability in systemic sclerosis patients.
Tickers: $CPIX